作者: G. Scagliotti , T. Kalebic , M. Volante , S. Cappia , S. Novello
DOI: 10.1200/JCO.2006.24.18_SUPPL.7049
关键词: Oncology 、 Pathology 、 Internal medicine 、 Case-control study 、 Lung cancer 、 Bone sialoprotein 、 Medicine 、 Non small cell
摘要: 7049 Background: Bone metastases (BM) in non small cell lung cancer (NSCLC) may be present at diagnosis or develop the follow up, are associated with a worse prognosis, and currently there n...